Back
S&P Global Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
73
SPGI
S&P Global
Last Price:
503.38
Seasonality Move:
5.86%
Buy
97
RYTM
Rhythm Pharmaceuticals
Last Price:
64.04
Seasonality Move:
9.98%
Buy
73
S&P Global (SPGI)
is a Buy
Is S&P Global a Buy, Sell or Hold?
- The current S&P Global [SPGI] share price is $507.26. The Score for SPGI is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- SPGI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
97
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $65.58. The Score for RYTM is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SPGI Stock Price Chart
What is S&P Global's stock price today?
-
The S&P Global share price today is $507.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPGI is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $65.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
SPGI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.39 | Sell |
| Relative Strength Index (14 RSI): | 54.99 | Buy |
| Chaikin Money Flow: | 468059 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (488.53 - 521.13) | Buy |
| Bollinger Bands (100): | (471.24 - 518.02) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.64 | Buy |
| Relative Strength Index (14 RSI): | 75.47 | Buy |
| Chaikin Money Flow: | -747845 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.34 - 58.08) | Buy |
| Bollinger Bands (100): | (43.86 - 53.38) | Buy |
SPGI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 492.04 | Buy |
| 20-day SMA: | 501.87 | Buy |
| 50-day SMA: | 510.86 | Sell |
| 200-day SMA: | 461.91 | Buy |
| 8-day EMA: | 496.92 | Buy |
| 20-day EMA: | 499.68 | Buy |
| 50-day EMA: | 502.24 | Buy |
| 200-day EMA: | 468.38 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.17 | Buy |
| 20-day SMA: | 53.22 | Buy |
| 50-day SMA: | 51.3 | Buy |
| 200-day SMA: | 45.17 | Buy |
| 8-day EMA: | 60.15 | Buy |
| 20-day EMA: | 55.23 | Buy |
| 50-day EMA: | 51.77 | Buy |
| 200-day EMA: | 44.82 | Buy |
S&P Global Earnings Growth & SPGI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.66 per share, and an increase next year of $1.53 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
S&P Global Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||